Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

H2QI45 (H2QI45_PANTR) Pan troglodytes (Chimpanzee)

T-complex protein 1 subunit eta UniProtKBInterProSTRINGInteractive Modelling

543 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: Q99832; Pan troglodytes: A0A6D2WF44

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CCT G beta 5 complex closed state 14 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 3 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex best PhLP1 class Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 4 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 6 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 13 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 12 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 15 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 5 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex close state 11 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 2 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 10 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 8 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 0 Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 7 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 1 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 9 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
1-528
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC-tubulin-S3 Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-526
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ADP-AlFx Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-526
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ATP-closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-526
Assess
Human TRiC complex in closed state with nanobody and tubulin bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13885; Q99832;
1-524
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC-PhLP2A-actin complex in the closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4;
5-527
Assess
Human TRiC/CCT complex with reovirus outer capsid protein sigma-3 Heteromer
P03527; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-523
ZN;
Assess
Human TRiC in ATP/AlFx closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-523
Assess
The beta-tubulin folding intermediate IV Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
4-524
MG;ADP;AF3;
Assess
The beta-tubulin folding intermediate III Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
4-524
MG;ADP;AF3;
Assess
The beta-tubulin folding intermediate II Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
4-524
AF3;MG;ADP;
Assess
Human TRiC-PhLP2A complex in the closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
5-525
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody bound (Consensus Map) Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-524
16×ADP; 16×MG; 16×AF3;
Assess
The beta-tubulin folding intermediate I Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
4-523
MG;ADP;AF3;
Assess
Cryo-EM structure of human TRiC-tubulin-S2 Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-524
16×ATP;
Assess
Cryo-EM structure of human TRiC-NPP state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-524
Assess
cryo-EM structure of human TRiC-ADP Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-524
16×ADP;
Assess
Cryo-EM structure of Human TRiC-ATP-open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-524
Assess
Human TRiC open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-524
ADP;
Assess
hTRiC-hPFD Class1 (No PFD) Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-525
Assess
CCT G beta 5 complex intermediate state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-525
16×ADP;
Assess
hTRiC-hPFD Class3 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
12-525
Assess
hTRiC-hPFD Class4 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
12-525
Assess
hTRiC-hPFD Class5 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
12-525
Assess
Human CCT:mLST8 complex Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-525
ADP;
Assess
Open state CCT-G beta 5 complex Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-525
16×ADP;
Assess
hTRiC-hPFD Class2 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
12-525
Assess
hTRiC-hPFD Class6 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
12-525
Assess
Human TRiC complex in open state with nanobody bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
13-524
16×MG; 16×ADP; 12×AF3;
Assess
Human TRiC-PhLP2A complex in the open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
13-524
10×ADP;
Assess
Cryo-EM structure of human TRiC-tubulin-S1 state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
14-524
ADP;
Assess
Prefoldin-tubulin-TRiC complex Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
15-523
ADP;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7nvl.1.Fmonomer0.785-524
ADP;AF3;100.00
Assess